Could taking aspirin halve the risk of bowel cancer?

Episode 193

0:00-36:20

A daily low dose of aspirin could significantly reduce the risk of bowel cancer in people with Lynch syndrome, an inherited condition that increases the likelihood of developing certain cancers. In this episode, we explore the findings from the landmark CaPP3 trial, hear from a participant living with Lynch syndrome, and discuss how genomics could help shift healthcare from treatment to prevention. Our host, Sharon Jones is joined by: Dr Katie Snape, Principal Clinician for Population Health at Genomics England Professor Sir John Burn, Professor of Clinical Genetics at Newcastle University Drew Hyde, participant in the Ca...

Publisher

Behind the Genes

Link

genomicsengland.podbean.com/e/could-taking-aspirin-halve-the-risk-of-bowel-cancer/

Published

June 24, 2026

Duration

36 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Genomics England

BT

Behind the Genes

@behindthegenes

#takingaspirinhalve #risk #bowelcancer #lifesciences #socialsciences

The Nile